2015
DOI: 10.1515/pjs-2015-0075
|View full text |Cite
|
Sign up to set email alerts
|

Combination Therapy Of Tadalafil And Pentoxifylline In Severe Erectile Dysfunction; A Prospective Randomized Trial

Abstract: Both tadalafil and combination of Tadalafil + Pentoxifylline improve erectile function in patients of ED. Patients with severe ED showed much significant improvement in erectile function with combination therapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
21
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(21 citation statements)
references
References 22 publications
0
21
0
Order By: Relevance
“…Patients with severe ED in particular also experienced much greater improvements in EF with combination therapy. 16 Compared to our trial, the significant improvement in ED with combination therapy may be due to tadalafil's longer half-life (17.50 hours) compared to sildenafil (4À5 hours), but more randomized studies will be required to review this.…”
Section: Discussionmentioning
confidence: 68%
See 3 more Smart Citations
“…Patients with severe ED in particular also experienced much greater improvements in EF with combination therapy. 16 Compared to our trial, the significant improvement in ED with combination therapy may be due to tadalafil's longer half-life (17.50 hours) compared to sildenafil (4À5 hours), but more randomized studies will be required to review this.…”
Section: Discussionmentioning
confidence: 68%
“…In terms of the incidence of AEs between the 2 treatment arms, there were no significant differences. 12,16 Our trial reflected a relative high rate of noncompliance. 33% of the trial patients had a balance of >30 of 168 caplets dispensed.…”
Section: Discussionmentioning
confidence: 91%
See 2 more Smart Citations
“…They observed a slight improvement in IIEF scores in men with severe ED when compared to tadalafil alone. The clinical relevance is unclear and further studies need to be done to look at this further ( 65 ).…”
Section: Oral Therapiesmentioning
confidence: 99%